SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549


                                    FORM 8-K/A

                 CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D)
                     OF THE SECURITIES EXCHANGE ACT OF 1934


         DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): January 10, 2001


                          BIOSHIELD TECHNOLOGIES, INC.
             (EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)


            GEORGIA                       0-24913                 58-2181628
- -------------------------------------------------------------------------------
(STATE OR OTHER JURISDICTION OF   (COMMISSION FILE NUMBER)  (I.R.S. EMPLOYER
 INCORPORATION OR ORGANIZATION)                             IDENTIFICATION NO.)



4405 International Blvd.
NORCROSS, GEORGIA 30093

REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE:            (770) 925-3653



          (FORMER NAME OR FORMER ADDRESS, IF CHANGED SINCE LAST REPORT)

ITEM 4.       Changes in Registrant's Certifying Accountant.


         On January 10, 2001,  the  Registrant  received a letter of resignation
from the  Registrant's  independent  accountants,  Grant  Thornton,  LLP,  dated
January 9, 2001. The Company is  interviewing a replacement  firm and intends to
select new independent accountants shortly.

         During the Registrant's two most recent fiscal years and any subsequent
interim periods  preceding the date of resignation,  there were no disagreements
between the accounting  principles or practices,  financial statement disclosure
or auditing scope or procedure,  which,  if not resolved to the  satisfaction of
the former independent accountants,  would have caused them to make reference to
the subject  matter of the  disagreement  in their report.  The reports of Grant
Thornton, LLP on the consolidated financial statements of the Registrant for the
two most recent fiscal years and the  subsequent  interim  period  preceding the
date of resignation did not contain any adverse opinion or disclaimer or opinion
nor were such reports  qualified or modified as to  uncertainty,  audit scope or
accounting principles.

On November 14, 2000,  Grant  Thornton,  LLP  provided  management  with a draft
report in accordance  with  Statement of Auditing  Standards No. 61. This report
discussed   observations  made  during  Grant  Thornton,   LLP's  audit  of  the
Registrant's  fiscal year ended June 30,  2000.  The draft  report  identifies a
"reportable  condition" as defined by the American Institute of Certified Public
Accountants  related to lapses in internal  control  resulting from  significant
turnover of accounting  personnel  during the fiscal year and the  corresponding
effect this turnover had on the system of internal controls. Discussions related
to the lapses in internal  control had  previously  taken  place  between  Grant
Thornton,  LLP and the audit  committee of the Registrant on August 23, 2000. In
mid December of 2000,  management  received a final report letter dated November
14, 2000 identifying the same reportable condition noted in the draft.

On January 29, 2001, the Registrant engaged Feldman,  Sherb and Company, P.C. as
its independent accountants.  The change of independent accountants was approved
by the Board of Directors of the Company.


Item 7.      Financial Statements, Pro Forma Financial Information and Exhibits.

                {c} Exhibits:   Letter to the Securities and Exchange Commission
                                from Grant Thornton, LLP


April 3, 2001



Securities and Exchange Commission
Mail Stop 11-3
450 Fifth Street, NW
Washington, DC  20549

Dear Sirs/Madam:

                  We  have  read   Item  4  in  the  Form  8K/A  for   BioShield
                  Technologies,  Inc.,  with date of report of January  10, 2001
                  dated  January  18,  2001 and filed  with the  Securities  and
                  Exchange  Commission,  January 18,  2001,and  are in agreement
                  with the statements  contained  therein insofar as they relate
                  to our firm. We have no basis of agreeing or disagreeing  with
                  the statements  made in the fourth  paragraph  relating to the
                  appointment of new independent  accountants or approval of the
                  board of directors.

                  Very truly yours,


                  /s/Grant Thornton, LLP




                                               SIGNATURES

         Pursuant to the  requirements  of the Securities  Exchange Act of 1934,
the  Registrant  has duly  caused  this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                               BIOSHIELD TECHNOLOGIES, INC.
                                               (Registrant)


Date: April 3, 2001                            /s/ Timothy C. Moses



                                               TIMOTHY C. MOSES
                                           President and Chief Executive Officer